Article Information
History
- April 7, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Marie C. Sadler1,2,3,
- Alexander Apostolov3,
- Caterina Cevallos4,
- Diogo M. Ribeiro3,
- Russ B. Altman5 and
- Zoltán Kutalik1,2,3,*
- 1University Center for Primary Care and Public Health, Lausanne, Switzerland
- 2Swiss Institute of Bioinformatics, Lausanne, Switzerland
- 3Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
- 4Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
- 5Department of Bioengineering, Stanford University, Stanford, CA, USA
- ↵*Corresponding author: zoltan.kutalik{at}unil.ch
Posted April 07, 2024.
Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medications
